Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 218
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
BMC Cancer ; 24(1): 443, 2024 Apr 10.
Artículo en Inglés | MEDLINE | ID: mdl-38600440

RESUMEN

BACKGROUND: Altered glycosylation is a hallmark of cancer associated with therapy resistance and tumor behavior. In this study, we investigated the glycosylation profile of stemness-related proteins OCT4, CIP2A, MET, and LIMA1 in HNSCC tumors. METHODS: Tumor, adjacent normal tissue, and blood samples of 25 patients were collected together with clinical details. After tissue processing, lectin-based glycovariant screens were performed. RESULTS: Strong correlation between glycosylation profiles of all four stemness-related proteins was observed in tumor tissue, whereas glycosylation in tumor tissue, adjacent normal tissue, and serum was differential. CONCLUSIONS: A mannose- and galactose-rich glycosylation niche associated with stemness-related proteins was identified.


Asunto(s)
Carcinoma de Células Escamosas , Neoplasias de Cabeza y Cuello , Humanos , Carcinoma de Células Escamosas de Cabeza y Cuello , Carcinoma de Células Escamosas/patología , Glicosilación , Línea Celular Tumoral , Proteínas del Citoesqueleto/metabolismo
2.
Acta Paediatr ; 107(8): 1322-1326, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29603358

RESUMEN

AIM: Extensive ongoing research on probiotics and infant formulas raises a number of safety questions. One concern is the potential influence of d-lactic acid-containing preparations on the health of infants and children. The aim of this review was to summarise the available knowledge on the ingestion of d-lactic acid-producing bacteria, acidified infant formulas and fermented infant formulas as a potential cause of paediatric d-lactic acidosis. METHODS: A Medline database search was performed in July 2017, with no restrictions on the language, article type or publication date. The 1715 search results were screened for clinical trials, review articles, case series and case reports of relevance to the topic. RESULTS: We identified five randomised controlled trials from 2005 to 2017 covering 544 healthy infants and some case reports and experimental studies. No clinically relevant adverse effects of d-lactic acid-producing probiotics and fermented infant formulas were described in healthy children. However, a harmless, subclinical accumulation of d-lactate was theoretically possible. The only known cases of paediatric d-lactic acidosis occurred in patients with short bowel syndrome or, historically, in infants fed with acidified formulas. CONCLUSION: Our main finding was that probiotics and fermented formulas did not cause d-lactic acidosis in healthy children.


Asunto(s)
Acidosis Láctica/etiología , Fórmulas Infantiles/química , Salud del Lactante , Ácido Láctico/administración & dosificación , Probióticos/uso terapéutico , Acidosis Láctica/fisiopatología , Preescolar , Femenino , Fermentación , Humanos , Lactante , Masculino , Probióticos/efectos adversos , Ensayos Clínicos Controlados Aleatorios como Asunto , Medición de Riesgo , Sensibilidad y Especificidad
3.
Acta Paediatr ; 106(7): 1103-1109, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28316118

RESUMEN

AIM: Preterm infants display aberrant gut microbial colonisation. We investigated whether the differences in gut microbiota between late preterm and full-term infants results from prematurity or external exposures. METHODS: This study comprised 43 late preterm infants (340/7 -366/7 ) and 75 full-term infants based on faecal samples collected following birth and at two to four weeks and six months of age. We assessed clinically relevant bacteria using quantitative polymerase chain reaction. Logistic regression analyses were performed to determine whether the observed differences in gut microbiota were attributable to prematurity or perinatal exposure. RESULTS: The prevalence of bifidobacteria differed in the intestinal microbiota of the full-term and late preterm neonates. Differences in the presence of specific species were detected at the age of six months, although the microbiota alterations were most prominent following delivery. As well as prematurity, the mode of birth, intrapartum and neonatal antibiotic exposure, and the duration of breastfeeding had an additional impact on gut microbiota development. CONCLUSION: The gut microbiota composition was significantly different between late preterm and full-term infants at least six months after birth. Antibiotic exposure was common in late preterm infants and modulated gut colonisation, but preterm birth also affected gut microbiota development independently.


Asunto(s)
Microbioma Gastrointestinal , Recien Nacido Prematuro , Adulto , Antibacterianos/efectos adversos , Femenino , Microbioma Gastrointestinal/efectos de los fármacos , Humanos , Recién Nacido , Embarazo , Adulto Joven
4.
Allergy ; 70(2): 241-4, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25413686

RESUMEN

The reports on atopic diseases and microbiota in early childhood remain contradictory, and both decreased and increased microbiota diversity have been associated with atopic eczema. In this study, the intestinal microbiota signatures associated with the severity of eczema in 6-month-old infants were characterized. Further, the changes in intestinal microbiota composition related to the improvement of this disease 3 months later were assessed. The severity of eczema correlated inversely with microbiota diversity (r = -0.54, P = 0.002) and with the abundance of butyrate-producing bacteria (r = -0.52, P = 0.005). During the 3-month follow-up, microbiota diversity increased (P < 0.001) and scoring atopic dermatitis values decreased (P < 0.001) in all infants. This decrease coincided with the increase in bacteria related to butyrate-producing Coprococcus eutactus (r = -0.59, P = 0.02). In conclusion, the high diversity of microbiota and high abundance of butyrate-producing bacteria were associated with milder eczema, thus suggesting they have a role in alleviating symptoms of atopic eczema.


Asunto(s)
Bacterias/metabolismo , Butiratos/metabolismo , Hipersensibilidad Inmediata/diagnóstico , Hipersensibilidad Inmediata/etiología , Intestinos/microbiología , Microbiota , Biodiversidad , Dermatitis Atópica/diagnóstico , Dermatitis Atópica/etiología , Eccema/diagnóstico , Eccema/etiología , Estudios de Seguimiento , Humanos , Lactante , Índice de Severidad de la Enfermedad
5.
Diabetes Obes Metab ; 17(8): 713-9, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25885278

RESUMEN

Overweight and obesity currently constitute a major threat to human well-being. Almost half of the female population are currently overweight. Pregnant overweight women are at risk of gestational diabetes affecting the health of the mother and the child, in both the short and long term. Notwithstanding the extensive scientific interest centred on the problem, research efforts have thus far been unable to devise preventive strategies. Recent scientific advances point to a gut microbiota dysbiosis, with ensuing low-grade inflammation as a contributing element, in obesity and its comorbidities. Such findings would suggest a role for specific probiotics in the search for preventive and therapeutic adjunct applications in gestational diabetes. The aim of the present paper was to critically review recent demonstrations of the role of intestinal microbes in immune and metabolic regulation, which could be exploited in nutritional management of pregnant women by probiotic bacteria. By modulating specific target functions, probiotic dietary intervention may exert clinical effects beyond the nutritional impact of food. As this approach in pregnancy is new, an overview of the role of gut microbiota in shaping host metabolism, together with the definition of probiotics are presented, and finally, specific targets and potential mechanisms for probiotics in pregnancy are discussed. Pregnancy appears to be the most critical stage for interventions aiming to reduce the risk of non-communicable disease in future generations, beyond the immediate dangers attributable to the health of the mother, labour and the neonate. Specific probiotic interventions during pregnancy provide an opportunity, therefore, to promote the health not only of the mother but also of the child.


Asunto(s)
Diabetes Gestacional/prevención & control , Probióticos/uso terapéutico , Diabetes Gestacional/microbiología , Femenino , Microbioma Gastrointestinal , Humanos , Mucosa Intestinal/metabolismo , Intestinos/microbiología , Sobrepeso/complicaciones , Sobrepeso/microbiología , Embarazo , Probióticos/metabolismo
6.
J Appl Microbiol ; 117(1): 239-48, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24724909

RESUMEN

AIMS: The purpose of this study was to investigate the heat-shock response at molecular level in Lactobacillus rhamnosus GG, Bifidobacterium animalis subsp. lactis BB-12 and their heat-tolerant derivatives and to characterize the changes that make the derivatives more robust in terms of heat stress. METHODS AND RESULTS: The study strains were exposed for 2 h to a heat-shock treatment, Bif. animalis subsp. lactis BB-12 and its derivative at 50°C and the Lact. rhamnosus GG and its derivative at 60°C. Protein synthesis before and after heat shock was examined using proteomics and RT-qPCR. The analysis revealed that the regulation of seven proteins in both strain pairs was modified as a response to heat or between the original and the derivative strain. The comparison of wild-type strains and the heat-tolerant derivatives suggests that the acquisition of heat tolerance in the Bif. animalis subsp. lactis BB-12 derivative is due to a slightly increased constitutive level of chaperones, while in Lact. rhamnosus GG derivative, the main reason seems to be a higher ability to induce the production of chaperones. CONCLUSIONS: This study revealed possible markers of heat tolerance in B. lactis and Lact. rhamnosus strains. SIGNIFICANCE AND IMPACT OF STUDY: This study increases our knowledge on how Lactobacillus and Bifidobacterium strains may acquire heat tolerance. These findings may be useful for improving the heat tolerance of existing probiotic strains as well as screening new heat-tolerant strains.


Asunto(s)
Proteínas Bacterianas/genética , Bifidobacterium/genética , Regulación Bacteriana de la Expresión Génica , Respuesta al Choque Térmico/genética , Lacticaseibacillus rhamnosus/genética , Chaperonas Moleculares/genética , Proteínas Bacterianas/metabolismo , Bifidobacterium/metabolismo , Calor , Humanos , Lacticaseibacillus rhamnosus/metabolismo , Chaperonas Moleculares/metabolismo , Probióticos/metabolismo , Biosíntesis de Proteínas
7.
J Appl Microbiol ; 116(5): 1308-14, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24779583

RESUMEN

AIMS: Manufacturing process used in preparation of probiotic products may alter beneficial properties of probiotics. The effect of different growth media and inactivation methods on the protective properties of canine-originated probiotic bacteria against adhesion of canine enteropathogens was investigated. METHODS AND RESULTS: Three established dog probiotics, Lactobacillus fermentum VET9A, Lactobacillus plantarum VET14A and Lactobacillus rhamnosus VET16A, and their mixture were assessed using the dog mucus pathogen exclusion model. The pathogens used were Enterococcus canis, Salmonella enterica serovar Typhimurium and Clostridium perfringens. The effect of growth media, one reflecting laboratory and the other manufacture conditions, and viability (viable and heat inactivated, 80°C per 30 min) on the pathogen exclusion properties of probiotics were characterized. Greater pathogen exclusion percentages were noted for probiotics growing in conditions reflecting manufacture when compared to laboratory (P < 0·05). Inactivation of probiotics by heat (80°C per 30 min) increased pathogen exclusion compared with their viable forms (P < 0·05). CONCLUSIONS: Manufacturing process conditions such as growth media, incubation temperature and pretreatment methods may significantly affect the protective properties of the tested strains. SIGNIFICANCE AND IMPACT OF THE STUDY: Growing conditions and pretreatment methods should be carefully considered when designing new probiotics to reduce the risk of common infections in dogs. The studied probiotics are promising potential feed additives for dogs.


Asunto(s)
Medios de Cultivo , Perros/microbiología , Lactobacillus/fisiología , Probióticos , Animales , Adhesión Bacteriana , Clostridium perfringens/fisiología , Enterococcus/fisiología , Lactobacillus/crecimiento & desarrollo , Limosilactobacillus fermentum/crecimiento & desarrollo , Limosilactobacillus fermentum/fisiología , Lactobacillus plantarum/crecimiento & desarrollo , Lactobacillus plantarum/fisiología , Lacticaseibacillus rhamnosus/crecimiento & desarrollo , Lacticaseibacillus rhamnosus/fisiología , Moco/microbiología , Salmonella typhimurium/fisiología
8.
J Appl Microbiol ; 115(2): 539-45, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23617818

RESUMEN

AIMS: The manufacturing processes have been reported to influence the properties of probiotics with potential impact on health properties. The aim was to investigate the effect of different growth media and inactivation methods on the properties of canine-originated probiotic bacteria alone and in combination mixture. METHODS AND RESULTS: Three established dog probiotics, Lactobacillus fermentum VET9A, Lactobacillus plantarum VET14A and Lactobacillus rhamnosus VET16A, and their combination mixture were evaluated for their adhesion to dog mucus. The effect of different growth media, one reflecting laboratory and the other manufacturing conditions, and inactivation methods (95°C, 80°C and UV irradiation) on the mucus adhesion of the probiotic strains was characterized. Evaluation of dog probiotics was supported by cell visualization using transmission electron microscopy (TEM). Higher adhesion percentage was reported for probiotic strains growing in laboratory rather than in manufacturing conditions (P < 0.05). Inactivation by heat (95°C, 80°C) decreased the adhesion properties when strains were cultivated in soy-based growth media compared with those grown in MRS broth (P < 0.05). TEM observations uncovered differences in cell-surface components in nonviable forms of probiotic strains as compared with their viable forms. CONCLUSIONS: Manufacturing process conditions such as growth media and pretreatment methods may significantly affect the adhesive ability of the tested strains. SIGNIFICANCE AND IMPACT OF THE STUDY: Growth conditions, growth media, pretreatment methods and different probiotic combinations should be carefully considered for quality control of existing probiotics and for identification of new probiotics for dogs. These may also have an impact on health benefits for the host.


Asunto(s)
Adhesión Bacteriana , Perros/microbiología , Lactobacillus/fisiología , Probióticos , Animales , Medios de Cultivo , Limosilactobacillus fermentum/crecimiento & desarrollo , Limosilactobacillus fermentum/fisiología , Lactobacillus plantarum/crecimiento & desarrollo , Lactobacillus plantarum/fisiología , Lacticaseibacillus rhamnosus/crecimiento & desarrollo , Lacticaseibacillus rhamnosus/fisiología , Moco/microbiología
9.
Ann Nutr Metab ; 63 Suppl 2: 17-26, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24217033

RESUMEN

Overweight and obesity can currently be considered a major threat to human health and well-being. Recent scientific advances point to an aberrant compositional development of the gut microbiota and low-grade inflammation as contributing factors, in conjunction with excessive energy intake. A high-fat/energy diet alters the gut microbiota composition, which reciprocally engenders excessive energy harvesting and storage. Further, microbial imbalance increases gut permeability, leading to metabolic endotoxemia, inflammation and insulin resistance. Local intestinal immunologic homeostasis is achieved by tolerogenic immune responses to microbial antigens. In the context of amelioration of insulin sensitivity and decreased adiposity, the potential of gut microbiota modulation with specific probiotics and prebiotics lies in the normalization of aberrant microbiota, improved gut barrier function and creation of an anti-inflammatory milieu. This would suggest a role for probiotic/prebiotic interventions in the search for preventive and therapeutic applications in weight management.


Asunto(s)
Intestinos/microbiología , Microbiota/fisiología , Obesidad , Dieta , Femenino , Humanos , Lactante , Fenómenos Fisiológicos Nutricionales del Lactante , Recién Nacido , Inflamación , Bienestar Materno , Estado Nutricional , Obesidad/prevención & control , Sobrepeso/prevención & control , Obesidad Infantil/prevención & control , Prebióticos , Embarazo , Probióticos , Factores de Riesgo
10.
Br J Nutr ; 108(9): 1714-20, 2012 Nov 14.
Artículo en Inglés | MEDLINE | ID: mdl-22947201

RESUMEN

Improving health through better nutrition of the population may contribute to enhanced efficiency and sustainability of healthcare systems. A recent expert meeting investigated in detail a number of methodological aspects related to the discipline of nutrition economics. The role of nutrition in health maintenance and in the prevention of non-communicable diseases is now generally recognised. However, the main scope of those seeking to contain healthcare expenditures tends to focus on the management of existing chronic diseases. Identifying additional relevant dimensions to measure and the context of use will become increasingly important in selecting and developing outcome measurements for nutrition interventions. The translation of nutrition-related research data into public health guidance raises the challenging issue of carrying out more pragmatic trials in many areas where these would generate the most useful evidence for health policy decision-making. Nutrition exemplifies all the types of interventions and policy which need evaluating across the health field. There is a need to start actively engaging key stakeholders in order to collect data and to widen health technology assessment approaches for achieving a policy shift from evidence-based medicine to evidence-based decision-making in the field of nutrition.


Asunto(s)
Ensayos Clínicos como Asunto/economía , Dieta/economía , Trastornos Nutricionales/prevención & control , Tecnología Biomédica/economía , Costos y Análisis de Costo/métodos , Medicina Basada en la Evidencia/economía , Humanos , Trastornos Nutricionales/economía , Política Nutricional
11.
Caries Res ; 46(1): 69-77, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22327347

RESUMEN

A randomized clinical trial studied the effects of early administration of Bifidobacterium animalis subsp. lactis BB-12 (BB-12) on oral colonization of (1) mutans streptococci (MS), and (2) BB-12. In this double-blind, placebo-controlled study, infants (n = 106) received probiotic bacteria (BB-12 group), xylitol (X group), or sorbitol (S group). Test tablets were administered twice a day (from the age of 1-2 months) with a novel slow-release pacifier or a spoon (daily dose of BB-12 10(10) CFU, polyol 200-600 mg). Samples were collected from mucosa/teeth at the age of 8 months and 2 years for BB- 12 determination (qPCR) and plate culturing of MS (MSB, TYCSB), lactobacilli (Rogosa) and yeasts (Sabouraud). The MS levels of the mothers were determined (Dentocult SM Strip Mutans). The baseline characteristics of the three groups were similar. Mean duration of tablet delivery was 14.9 ± 6.7 months. In all groups, >90% of the mothers showed high MS counts (log CFU ≥5). MS colonization percentages of the children at the age of 2 years were rather low (BB-12 group: 6%; X group: 31%; S group: 10%; p < 0.05). The levels of lactobacilli and yeasts did not differ between the groups. BB-12 cell counts barely exceeding the detection limit were found in three of the oral samples of the 8-month-old children; however, the 2-year samples did not contain BB-12. The early administration of BB-12 did not result in permanent oral colonization of this probiotic or significantly affect MS colonization in the children.


Asunto(s)
Bifidobacterium/fisiología , Boca/microbiología , Probióticos/uso terapéutico , Streptococcus mutans/fisiología , Carga Bacteriana , Bifidobacterium/aislamiento & purificación , Lactancia Materna , Candida albicans/aislamiento & purificación , Candida albicans/fisiología , Preparaciones de Acción Retardada , Placa Dental/microbiología , Método Doble Ciego , Femenino , Estudios de Seguimiento , Humanos , Lactante , Lactobacillus/aislamiento & purificación , Lactobacillus/fisiología , Masculino , Mucosa Bucal/microbiología , Chupetes , Placebos , Probióticos/administración & dosificación , Sorbitol/administración & dosificación , Sorbitol/uso terapéutico , Streptococcus sobrinus/aislamiento & purificación , Streptococcus sobrinus/fisiología , Comprimidos , Diente/microbiología , Cepillado Dental , Xilitol/administración & dosificación , Xilitol/uso terapéutico
12.
Clin Exp Allergy ; 41(3): 370-7, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21121981

RESUMEN

BACKGROUND: The intestinal mucosa functions as a defence barrier against gut intraluminar antigens. The maturational events in the gut parallel its step-wise colonization. Atopic dermatitis (AD) is associated with aberrant barrier functions of the skin epithelium and, in a subgroup of patients, of the gut mucosa. OBJECTIVE: To investigate the interaction of Lactobacillus rhamnosus GG (LGG) with skin and gut microbiota and humoral immunity in infants with AD. METHODS: Thirty-nine infants with AD were randomized for a 3-month period in a double-blind design to receive extensively hydrolysed casein formula supplemented with (n=19) or without (n=20) LGG (ATCC 53103) 5.0 × 107 CFU/g to achieve a daily intake of 3.4 × 109 CFU. Sampling (blood and fecal samples, cotton swab from the skin) was carried out at entry, 1 and 3 months thereafter. Ig-secreting cells were determined by enzyme-linked immunospot and the proportions of CD19(+)CD27(+) B cells among peripheral blood leucocytes by flow cytometry. The major groups of gut and skin bacteria were characterized using PCR. RESULTS: The proportions of IgA- and IgM-secreting cells decreased significantly in the treated group; the baseline-adjusted ratios for treated vs. untreated at 1 month were 0.59 (95%CI 0.36-0.99, P=0.044) for IgA- and 0.53 (95%CI 0.29-0.96, P=0.036) for IgM-secreting cells. The proportions of CD19(+)CD27(+) B cells increased in the probiotic-treated infants but not in the untreated. There were no significant differences in bifidobacterial species composition of the gut between the study groups. On the skin, the bacterial counts of Bifidobacterium genus vs. Clostridium coccoides in the treated and untreated infants were similar. CONCLUSION AND CLINICAL RELEVANCE: Specific probiotics may enhance gut barrier function and aid in the development of immune responses. Thus, specific probiotics may afford protection against offending macromolecules in the gut and provide control for future infections by accelerated immunological maturation (ClinicalTrials.gov ID NCT01148667).


Asunto(s)
Dermatitis Atópica/inmunología , Mucosa Intestinal/microbiología , Lacticaseibacillus rhamnosus/inmunología , Probióticos/administración & dosificación , Piel/microbiología , Administración Oral , Subgrupos de Linfocitos B/inmunología , Separación Celular , Método Doble Ciego , Ensayo de Inmunoadsorción Enzimática , Citometría de Flujo , Humanos , Inmunidad Humoral/efectos de los fármacos , Inmunidad Humoral/inmunología , Lactante , Fórmulas Infantiles/química , Mucosa Intestinal/efectos de los fármacos , Reacción en Cadena de la Polimerasa , Piel/efectos de los fármacos
13.
Br J Nutr ; 105(1): 157-66, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20797310

RESUMEN

There is a new merging of health economics and nutrition disciplines to assess the impact of diet on health and disease prevention and to characterise the health and economic aspects of specific changes in nutritional behaviour and nutrition recommendations. A rationale exists for developing the field of nutrition economics which could offer a better understanding of both nutrition, in the context of having a significant influence on health outcomes, and economics, in order to estimate the absolute and relative monetary impact of health measures. For this purpose, an expert meeting assessed questions aimed at clarifying the scope and identifying the key issues that should be taken into consideration in developing nutrition economics as a discipline that could potentially address important questions. We propose a first multidisciplinary outline for understanding the principles and particular characteristics of this emerging field. We summarise here the concepts and the observations of workshop participants and propose a basic setting for nutrition economics and health outcomes research as a novel discipline to support nutrition, health economics and health policy development in an evidence and health-benefit-based manner.


Asunto(s)
Dieta/economía , Promoción de la Salud/economía , Ciencias de la Nutrición/economía , Análisis Costo-Beneficio , Humanos , Evaluación de Resultado en la Atención de Salud
14.
Benef Microbes ; 12(4): 45-58, 2021 Aug 30.
Artículo en Inglés | MEDLINE | ID: mdl-34259617

RESUMEN

The interest on plant-based fermented food is in raise in Western countries. The aim of this study was to select interleukin (IL)-10 inducing strains for the development of potential probiotic plant-based fermented foods. Departing from a collection of 52 lactic acid bacteria (LAB) strains derived from plant material, in vitro co-culture with murine macrophages allowed us to narrow down the number of candidates to 21 strains able to induce IL-10 secretion. 14 of these strains were able to promote the production of tumour necrosis factor-α too. The capacity to induce IL-6 was used to further reduce the number of strains to 4, from which Lactiplantibacillus plantarum subsp. plantarum LpAv was selected to ferment oat and carrots. L. plantarum LpAv was able to ferment oat and carrots until reaching counts of ca. 108 and 109 cfu/ml. Fermented oat and carrots were orally administered to mice for 10 consecutive days and challenged with a single infective dose of Salmonella enterica serovar. Typhimurium. Counts of L. plantarum LpAv in fermented carrots were 9.23±0.05 cfu/ml and 9.27±0.01 cfu/ml, at day 1 and 10 of the feeding period. Fermented carrots were able to confer enhanced protection (80% of survival) against infection, when compared to control mice (less than 25% of survival). However, L. plantarum LpAv administered as pure culture was not able to confer protection against Salmonella infection. L. plantarum LpAv was selected among 52 plant-derived LAB and it was able to ferment oat and carrots, being only fermented carrots able to confer enhanced protection against Salmonella infection. A succession of in vitro to in vivo tests is proposed as a tool to narrow down the number of candidates when searching for potential novel probiotics from a collection of autochthonous strains.


Asunto(s)
Alimentos Fermentados , Lactobacillales , Probióticos , Infecciones por Salmonella , Animales , Avena , Daucus carota , Interleucina-10 , Ratones , Probióticos/farmacología , Infecciones por Salmonella/prevención & control
15.
Benef Microbes ; 11(7): 685-702, 2020 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-33161735

RESUMEN

Breast milk can be a source of potential probiotic bacteria, but the technological capacity of isolates obtained from this source is not always guaranteed. We aimed at isolating lactobacilli from breast milk samples collected in Argentina, focusing on isolates with functional and technological potential as probiotics. Fourteen Lactobacillus and one Bifidobacterium isolates were obtained from 164 samples donated by 104 mothers. The isolates preliminarily identified by MALDI-TOF, and then the identity was confirmed by partial 16S rRNA gene sequencing. Hydrophobicity was determined (hexadecane and xylene partition). The strains were also co-cultured with murine RAW 264.7 macrophages for screening the capacity to induce the anti-inflammatory cytokine interleukin (IL)-10. Hydrophobicity ranged from 7.4 and 95.9%. The strains Lactobacillus gasseri (70a and 70c) and Lactobacillus plantarum (73a and 73b) were the strains with a higher capacity to induce IL-10 production by macrophages. The technological application was evaluated by freezing dried in 10% lactose or 10% polydextrose. The survival was assessed after accelerated (37 °C, 4 weeks) or long-term (5 and 25 °C, 12 months) storage. Except for Lactobacillus gallinarum 94d, strains lost less than 1 Log10 order cfu/g after long-term (12 months) storage at 5 °C in lactose and polydextrose as protectants. A low correlation between survival to accelerated and long-term storage tests was observed. L. gasseri (70a and 70c) and L. plantarum (73a and 73b) deserve further studies as potential probiotics due to their capacity to induce IL-10 from murine macrophages and their hydrophobicity. In special, L. plantarum 73a was able to confer enhanced protection against Salmonella infection by promoting the immunity of the small intestine.


Asunto(s)
Bacterias/aislamiento & purificación , Leche Humana/microbiología , Probióticos , Animales , Argentina , Bacterias/clasificación , Bacterias/genética , Bacterias/crecimiento & desarrollo , Medios de Cultivo , Femenino , Liofilización , Variación Genética , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Interleucina-10/metabolismo , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Ratones , Viabilidad Microbiana , Probióticos/química , Probióticos/farmacología
16.
Lett Appl Microbiol ; 48(1): 8-12, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19018955

RESUMEN

AIMS: Bifidobacteria and lactobacilli are part of the human normal intestinal microbiota and may possibly be transferred to the placenta. It was hypothesized that intestinal bacteria or their components are present in the placenta and that the foetus may be exposed to them. We investigated the presence of bifidobacteria and lactobacilli and their DNA in the human placenta. METHODS AND RESULTS: We studied 34 human placentae (25 vaginal and nine caesarean deliveries) for the presence Bifidobacterium spp. and Lactobacillus rhamnosus. Cultivation was used for the detection of viable cells and genus and species-specific PCR for the detection of DNA. No bifidobacteria or lactobacilli were found by cultivation. Bifidobacterial DNA was detected in 33 and L. rhamnosus DNA in 31 placenta samples. CONCLUSIONS: DNA from intestinal bacteria was found in most placenta samples. The results suggest that horizontal transfer of bacterial DNA from mother to foetus may occur via placenta. SIGNIFICANCE AND IMPACT OF THE STUDY: Bacterial DNA contains unmethylated CpG oligodeoxynucleotide motifs which induce immune effects. Specific CpG motifs activate Toll-like receptor 9 and subsequently trigger Th-1-type immune responses. Although the newborn infant is considered immunologically immature, exposure by bacterial DNA may programme the infant's immune development during foetal life earlier than previously considered.


Asunto(s)
Bifidobacterium/aislamiento & purificación , ADN Bacteriano/aislamiento & purificación , Lactobacillus/aislamiento & purificación , Placenta/microbiología , Bifidobacterium/genética , Femenino , Humanos , Lactobacillus/genética , Relaciones Materno-Fetales , Reacción en Cadena de la Polimerasa
17.
Benef Microbes ; 10(7): 711-719, 2019 Oct 14.
Artículo en Inglés | MEDLINE | ID: mdl-31965850

RESUMEN

The past definitions of probiotics and prebiotics have been reviewed and updated recently. According to these concepts, probiotics comprise live microorganisms that confer a health benefit on the host when administered in adequate amounts, whereas a prebiotic is a substrate that is selectively utilised by host microorganisms, conferring a health benefit. The words probiotics and prebiotics can be found on labels of many foods and supplements. Consumers have a growing awareness of these terms' meanings, and many countries are increasingly using them for regulation purposes. At the same time, there is increasing evidence on the health effects of non-viable microorganisms and the metabolites that they can produce by fermentation or by their action on food components. Different terms have been used in the literature to refer to these bioactive compounds, which do not fall under the known categories of probiotics, prebiotics or synbiotics. The tentative term postbiotics has been the most used one so far. However, no definition of the term has gained international consensus to date. This work aims to provide information on the facts and the open questions about the so-called postbiotics.


Asunto(s)
Productos Biológicos/uso terapéutico , Prebióticos , Probióticos , Consenso , Fermentación , Humanos , Microbiota
18.
Cochrane Database Syst Rev ; (1): CD006398, 2008 Jan 23.
Artículo en Inglés | MEDLINE | ID: mdl-18254102

RESUMEN

BACKGROUND: Agriculture is more hazardous than most other industries. Many strategies have been introduced to reduce injuries in the field, yet the effectiveness of different interventions on occupational injuries still remains unclear. OBJECTIVES: This review aims to determine the effectiveness of interventions to prevent occupational injuries among workers in the agricultural industry compared to no interventions or to alternative interventions. SEARCH STRATEGY: Cochrane Central Register of Controlled Trials, Cochrane Injuries Group's specialised register, MEDLINE, EMBASE, PsychINFO, OSH-ROM (including NIOSHTIC and HSELINE) databases were searched up to June 2006. Reference lists of selected articles, relevant reviews and additional topic related databases and web sites were also searched. The searches were not restricted by language or publication status. SELECTION CRITERIA: Randomised controlled trials, cluster-randomised controlled trials, prospective cohort studies with a concurrent control group, and interrupted time series studies assessing any type of intervention aiming to prevent fatal or non-fatal injuries among workers in agriculture. DATA COLLECTION AND ANALYSIS: Two reviewers conducted data extraction and study quality assessment independently. Rate ratios of randomised controlled trials were calculated and the effect sizes were combined in a meta-analysis. Interrupted time series studies were reanalysed and each of them studied for having an immediate and a progressive effect. MAIN RESULTS: Five randomised controlled trials (RCTs) with 11,565 participants and three interrupted time series studies (ITSs) with 26.3 data points on average met the criteria. For educational interventions aiming at reducing injury rates among adults the pooled rate ratio after recalculation from effect sizes in three RCTs was 1.02 (95% CI 0.87 to 1.20). For educational interventions aiming at children the pooled rate ratio for injury rates in two RCTs was 1.27 (95% CI 0.51 to 3.16). One ITS that evaluated the effect of an intervention that included financial incentives decreased the injury level immediately after the intervention with an effect size of -2.68 (95% CI -3.80 to -1.56) but did not have a significant effect on the injury trend over time with an effect size of -0.22 (95% CI -0.47 to 0.03). One ITS study that evaluated the effect of legislation to ban Endosulfan pesticide on fatal pesticide poisonings increased the level of poisonings immediately after the introduction with an effect size of 2.20 (95% CI 0.97 to 3.43) but led to decrease in the trend of poisonings over time with an effect size of -2.15 (95% CI -2.64 to -1.66). One ITS study documented four different regulations aiming to increase the use of rollover protective structures (ROPS) on tractors and their effect on injuries and fatal injuries. The introduction of two different pieces of legislation requiring ROPS on new tractors sold after a certain date was associated with a decrease of fatal injuries over the long term (effect size -0.93 95% CI -1.02 to -0.03) but they were also associated with an increase of injuries in general (fatal and non-fatal injuries combined). Introduction of legislation requiring ROPS on all tractors, old tractors included, was not associated with a decrease but with an increase of injuries and fatal injuries over the long term. AUTHORS' CONCLUSIONS: The selected studies provided no evidence that educational interventions are effective in decreasing injury rates among agricultural workers. Financial incentives could reduce injury rates. Legislation to ban pesticides could be effective. Legislation expanding the use of safety devices (ROPS) on new tractors was associated with a decrease in fatal injuries.


Asunto(s)
Prevención de Accidentes/métodos , Accidentes de Trabajo/prevención & control , Agricultura , Heridas y Lesiones/prevención & control , Adolescente , Adulto , Niño , Humanos , Ensayos Clínicos Controlados Aleatorios como Asunto
19.
Food Chem Toxicol ; 46(2): 502-7, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17928120

RESUMEN

Lactobacillus plantarum strains IS-10506 and IS-20506 isolated from Indonesian traditional fermented milk, dadih, were screened for their ability to remove the cyanobacterial toxin microcystin-LR (MC-LR) from aqueous solution (100 microg/L) at 22 and 37 degrees C. The objective was to study the main environmental factors influencing the metabolic activity of L. plantarum in MC-LR removal. Residual MC-LR was quantified using HPLC. Non-viable cells inactivated by boiling or acid showed only low MC-LR removal (<23 %). Viable L. plantarum strain IS-10506 at pH 7, at 22 and 37 degrees C was able to remove MC-LR, 64% and 43%, respectively, after 30 h. Strain IS-20506 at pH 7, at 22 and 37 degrees C removed 92% and 45 %, respectively, after 30 h. At 37 degrees C, the removal of MC-LR was lower than at 22 degrees C. Supplementation with glucose (1%, 2%, and 3%, w/v) resulted in faster and higher removal of MC-LR at 37 degrees C, while at 22 degrees C it did not improve MC-LR removal. In the presence of 1 % glucose, IS-10506 and IS-20506 demonstrated significantly the most efficient removal of 80% and 65% of applied MC-LR, after 25 and 20 h, respectively, at pH 7, 37 degrees C. Viable cells as well as active metabolism play important roles in removing MC-LR. This finding offers new and economical tools for decontaminating microcystin containing water.


Asunto(s)
Inhibidores Enzimáticos/metabolismo , Glucosa/farmacología , Lactobacillus plantarum/efectos de los fármacos , Lactobacillus plantarum/metabolismo , Microcistinas/metabolismo , Edulcorantes/farmacología , Análisis de Varianza , Cromatografía Líquida de Alta Presión , Incubadoras , Toxinas Marinas , Purificación del Agua/métodos
20.
Lett Appl Microbiol ; 46(2): 160-5, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18028332

RESUMEN

AIMS: The primary objective of this study was to compare the removal of cadmium, lead, aflatoxin B1 and microcystin-LR from aqueous solution by Lactobacillus rhamnosus GG, L. rhamnosus LC705, Propionibacterium freudenreichii shermanii JS and Bifidobacterium breve Bbi99/E8, separately and in combination. METHODS AND RESULTS: The removal of toxins and heavy metals was assessed in batch experiments. The removal of all compounds was observed to be strain specific. The removal of lead by a combination of all the strains used was observed to be lower than could be predicted from the removal by single strains (P < 0.05). A similar trend was also observed with the other compounds studied. CONCLUSIONS: The results show that the toxin-removal capacity of a combination of strains of lactic acid bacteria is not the sum of their individual capacities. Therefore, pure single strains should be used when the goal is to remove single compounds. The use of combinations of strains may be beneficial when several compounds are removed together. This needs to be studied in future experiments. SIGNIFICANCE AND IMPACT OF THE STUDY: Lactic acid bacteria have been identified as potent tools for the decontamination of heavy metals, cyanotoxins and mycotoxins. The results of this study should be considered when selecting combinations of bacteria for the simultaneous removal of several toxic compounds.


Asunto(s)
Bacterias/crecimiento & desarrollo , Bacterias/metabolismo , Toxinas Bacterianas/metabolismo , Metales Pesados/metabolismo , Bifidobacterium/crecimiento & desarrollo , Bifidobacterium/metabolismo , Biodegradación Ambiental , Ecosistema , Lactobacillus/crecimiento & desarrollo , Lactobacillus/metabolismo , Propionibacterium/crecimiento & desarrollo , Propionibacterium/metabolismo , Microbiología del Agua
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA